| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,420,214 |
|
|
|
Indirect Value
|
$116,216 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,536,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KIN |
Kindred Biosciences, Inc. |
Director |
– • – |
2015-06-02 |
4 |
OE |
$0.32 |
$14,654 |
D/D |
17,083 |
69,583 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-02-06 |
4 |
S |
$12.80 |
$218,935 |
D/D |
(17,104) |
347,855 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2017-08-10 |
4 |
S |
$130.52 |
$2,415,403 |
D/D |
(18,506) |
69,424 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2016-02-01 |
4 |
OE |
$29.00 |
$539,400 |
D/D |
18,600 |
101,049 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2006-01-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
18,700 |
92,467 |
|
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2013-09-27 |
4 |
OE |
$5.79 |
$108,563 |
D/D |
18,750 |
48,750 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2015-07-31 |
4 |
S |
$131.73 |
$2,561,139 |
D/D |
(19,442) |
122,449 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2004-05-05 |
4 |
B |
$13.00 |
$260,000 |
D/D |
20,000 |
70,431 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-08-24 |
4 |
S |
$58.00 |
$1,160,924 |
I/I |
(20,000) |
437,842 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-11-10 |
4 |
S |
$58.50 |
$1,170,700 |
I/I |
(20,000) |
408,842 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2008-07-23 |
4 |
OE |
$12.81 |
$280,280 |
D/D |
20,000 |
228,027 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2012-02-21 |
4 |
B |
$6.12 |
$122,400 |
D/D |
20,000 |
427,304 |
2.39 |
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2012-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| XNPT |
Xenoport Inc |
Director |
– • – |
2013-05-22 |
4 |
B |
$5.49 |
$109,800 |
D/D |
20,000 |
30,000 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-03-15 |
4 |
B |
$5.13 |
$102,628 |
D/D |
20,000 |
287,919 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2013-11-08 |
4 |
S |
$11.73 |
$239,857 |
I/I |
(20,445) |
0 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • • |
2014-11-18 |
4 |
A |
$0.00 |
$0 |
I/I |
20,832 |
69,717 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2003-09-24 |
4 |
GA |
$0.00 |
$0 |
D/D |
20,833 |
50,431 |
|
- |
|
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2003-09-24 |
4 |
GA |
$0.00 |
$0 |
I/I |
20,833 |
20,833 |
|
- |
|
| VVUS |
Vivus Inc |
Director |
– • – |
2013-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
21,125 |
66,125 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2021-07-30 |
4 |
A |
$0.91 |
$20,000 |
D/D |
21,978 |
1,349,909 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2018-05-14 |
4 |
S |
$4.67 |
$105,232 |
I/I |
(22,553) |
213,167 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
Director |
– • – |
2017-04-07 |
4 |
A |
$0.63 |
$15,000 |
D/D |
23,809 |
1,819,738 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-05-11 |
4 |
B |
$4.85 |
$117,365 |
D/D |
24,200 |
321,440 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-12-28 |
4 |
AS |
$4.52 |
$110,317 |
I/I |
(24,291) |
268,535 |
0 |
- |
|
373 Records found
|
|
Page 11 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
